status: 301
content-length: 531
content-location: http://trib.al/NaaiXBQ
set-cookie: tribal="rwOZNeMPTAWQrYP7m7ONVA==";
 expires=Fri, 06 Jan 2034 23:13:40 GMT; Path=/; Version=2
server: nginx/1.4.4
connection: keep-alive
location: http://www.washingtonpost.com/business/economy/an-effective-eye-drug-is-available-for-50-but-many-doctors-choose-a-2000-alternative/2013/12/07/1a96628e-55e7-11e3-8304-caf30787c0a9_story.html?Post+generic=%3Ftid%3Dsm_twitter_washingtonpost
date: Wed, 24 Sep 2014 22:00:34 GMT
-x-permanent-redirect-url: http://www.washingtonpost.com/business/economy/an-effective-eye-drug-is-available-for-50-but-many-doctors-choose-a-2000-alternative/2013/12/07/1a96628e-55e7-11e3-8304-caf30787c0a9_story.html?Post+generic=%3Ftid%3Dsm_twitter_washingtonpost
content-type: text/html;charset=utf-8

This resource has permanently moved to <a href='http://www.washingtonpost.com/business/economy/an-effective-eye-drug-is-available-for-50-but-many-doctors-choose-a-2000-alternative/2013/12/07/1a96628e-55e7-11e3-8304-caf30787c0a9_story.html?Post+generic=%3Ftid%3Dsm_twitter_washingtonpost'>http://www.washingtonpost.com/business/economy/an-effective-eye-drug-is-available-for-50-but-many-doctors-choose-a-2000-alternative/2013/12/07/1a96628e-55e7-11e3-8304-caf30787c0a9_story.html?Post+generic=%3Ftid%3Dsm_twitter_washingtonpost</a>.